Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test substance was tested for acute oral toxicity to rats according to OECD guideline No. 423: "Acute Oral Toxicity, Acute Toxic Class Method", adopted 2001 and Commission regulation (EC) No. 440/2008 of 30 May 2008, Part B.1 tris: “Acute Oral Toxicity, Acute Toxic Class Method”, Publication No. L142.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2014-07-08 to 2014-08-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted under GLP conditions in accordance with the OECD guideline No 423 (2001).
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- (2001)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- (May, 2008)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- (2002)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Strain: Wistar Crl: WI (Han)
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation: young adult animals (8-9 weeks)
- Weight at study initiation: 143 - 185 g
- Fasting period before study: overnight prior to dosing and until 3-4 hours after administration of the test substance
- Housing: group housing of 3 animals per cage
- Diet (e.g. ad libitum): pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany) ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Justification for choice of vehicle: The vehicle was selected based on trial formulations performed at WIL Research Europe and on test substance data supplied by the sponsor.
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: assumed low toxic effects - Doses:
- 2000 mg/kg (10 mL/kg) body weight.
300 mg/kg (10 mL/kg) body weight. - No. of animals per sex per dose:
- 3 animals per dose (total of 12 animals)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Days 1 (pre-administration), 8 and 15 and at death (if found dead or sacrificed after Day 1).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- No statistical analysis was performed.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- At 2000 mg/kg, three out of six animals were found dead on Day 2 or 3.
At 300 mg/kg, no mortality occurred. - Clinical signs:
- At 2000 mg/kg, lethargy, hunched posture, piloerection, ptosis and/or diarrhea were noted for the animals between Days 1 and 9.
At 300 mg/kg, hunched posture and/or piloerection, were noted for the animals on Day 1. - Body weight:
- At 2000 mg/kg, one of the surviving animals showed slight body weight loss between Days 1 and 8. Other animals showed expected body weight gain.
- Gross pathology:
- At 2000 mg/kg, abnormalities of the stomach and small intestines (contents: gelatinous) were found in one of the animals found dead.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 value of Lithium salt of branched-aliphatic dicarboxylic acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight. - Executive summary:
The oral LD50 value of Lithium salt of branched-aliphatic dicarboxylic acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.
Based on these results:
- according to the Globally Harmonised System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments),
Lithium salt of branched-aliphatic dicarboxylic acid should be classified as: harmful if swallowed (Category 4) for acute toxicity by the oral route.
- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments),
Lithium salt of branched-aliphatic dicarboxylic acid should be classified as Category 4 and should be labelled as H302: Harmful if swallowed.
Reference
Table 1. Mean body weights
Sex / dose level |
Mean weight +/- St.Deviation (g) |
||
Day 1 |
Day 8 |
Day 15 |
|
Females 2000 mg/kg |
153 +/- 9 |
166 +/- 8 |
196 +/- 1 |
Females 2000 mg/kg |
176 +/- 11 |
174 |
198 |
Females 300 mg/kg |
177 +/- 8 |
198 +/- 9 |
209 +/- 7 |
Females 300 mg/kg |
157 +/- 7 |
187 +/- 6 |
202 +/- 11 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
The acute oral toxicity of Lithium salt of branched-aliphatic dicarboxylic acid to rats was evaluated in a reliable study according to the appropriate standard test methods EU Method B.1 tris (Acute Oral Toxicity, Acute Toxic Class Method), OECD Guideline 423 (Acute Oral Toxicity - Acute Toxic Class Method) and EPA, OPPTS870.1100 (2002) “Acute Oral Toxicity”.
The oral LD50 value of Lithium salt of branched-aliphatic dicarboxylic acid in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
According to the OECD 423 test guideline, the LD50 cut-off value was considered to be 2000 mg/kg body weight.
Based on these results:
- according to the Globally Harmonised System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments), Lithium salt of branched-aliphatic dicarboxylic acid should be classified as: harmful if swallowed (Category 4) for acute toxicity by the oral route.
- according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments), Lithium salt of branched-aliphatic dicarboxylic acid should be classified as Category 4 and should be labelled as H302: Harmful if swallowed.
Justification for selection of acute toxicity – oral endpoint
The study was conducted under GLP conditions according to OECD guideline 429 and matched the requirements of Annex 7 of the REACH legislation.
Justification for classification or non-classification
The LD50 cut-off value was considered to be 2000 mg/kg body weight.
According to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments), Lithium salt of branched-aliphatic dicarboxylic acid should be classified as Harmful if swallowed (Category 4) for acute toxicity by the oral route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.